Safety Assessment of Nanomaterials at the Joint Research Centre
|
|
- Jessica Blair
- 8 years ago
- Views:
Transcription
1 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Safety Assessment of Nanomaterials at the Joint Research Centre Hermann Stamm Institute for Health and Consumer Protection Joint Research Centre, Ispra * The views expressed in this presentation are personal and may not necessarily reflect those of the European Commission
2 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Research-Based Policy Support JRC - Robust Science for Policy Making As a Directorate-General of the European Commission, the JRC provides customer-driven scientific and technical support to Community policy making Supporting citizen s security, health and environmental protection, safety of food and chemicals, alternative energies, nuclear safety, econometrics, prospective technologies
3 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Our Structure: 7 Institutes in 5 Member States IHCP - Ispra, Italy Institute for Health and Consumer Protection IES - Ispra, Italy Institute for Environment and Sustainability IPSC - Ispra, Italy Institute for the Protection and Security of the Citizen IRMM - Geel, Belgium Institute for Reference Materials and Measurements IE - Petten, The Netherlands Institute for Energy ITU - Karlsruhe, Germany Institute for Transuranium Elements IPTS - Seville, Spain Institute for Prospective Technological Studies
4 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Nanomaterials (NM) Safety Assessment Assessment Methodology Substance identification Information requirements Test methods and testing strategies Safety and risk assessment REACH Implementation Projects on Nano (RIPoN) Steering group: ENV, ENTR, ECHA, JRC Provide Implementation Tools Information Platform: NAPIRAhub Test Assessment Methods Nanomaterials for testing: Repository Provide data for safety assessment Data evaluation reports for nanosafety Databases for safety assessment
5 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March JRC Nanotechnology Policy Support European Commission Testing and guidelines (OECD) Member states Standardization Committees (ISO, CEN) EFSA Working Group on Nanotechnology Collaboration on nanotechnology related issues with ECHA
6 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March EU Regulation Nanotechnology Relevance Horizontal Legislation 1. Chemicals Legislation (REACH) Product Legislation 2. Safety Worker aspects Protection regarding nanotechnologies Plant are Protection in principle Products covered. 3. Environmental Legislation Integrated Pollution Prevention and Control Major-accidents, Seveso II Directive Water Waste General Safety of Consumer Products Biocides Need for modification? New Approach Legislation Cosmetic Products Aerosol Dispensers Medicinal Products Cars Food Legislation
7 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Requirements Definition of Nanomaterials for Regulatory Purposes A single definition broadly applicable in EU legislation and policies Legally clear and unambiguous, i.e. enforceable In line with other approaches world-wide Questions concerning the key elements of a definition What is a material (in the context of nanomaterial)? What is the nanoscale and which size range should it encompass? Should other properties which are the consequence of the material being at the nanoscale be included?
8 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March OECD Working Party for Manufactured Nanomaterials In 2006, the OECD established the Working Party on Manufactured Nanomaterials (WPMN). Objective: To promote international co-operation in human health and environmental safety related aspects of manufactured nanomaterials (MNs), in order to assist in the development of rigorous safety evaluation of nanomaterials.
9 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Work Area 1 Characterisation, Definition, Terminology and Standards OECD Working Party on Manufactured Nanomaterials (WPMN) Work Area 2 Testing Methods and Risk Assessment Project 3: Sponsorship Programme: Nanomaterial Measurement and Testing OECD WPMN Project 5: Voluntary Schemes and Regulatory Programmes Work Area 3 Information sharing, Co - operation and Dissemination Project 1 and 2: Nanosafety Projects Database Project 4: Manufactured Nanomaterials and Test Guidelines Project 6: Risk Assessment Project 7: Alternative Test methods and Testing Strategies Project 8: Exposure Measurements
10 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Nanomaterials Safety Assessment Assessment Methodology Substance identification Information requirements Test methods and testing strategies Safety and risk assessment Provide Implementation Tools Information Platform: NAPIRAhub Test Assessment Methods Nanomaterials for testing: Repository Provide data for safety assessment Data evaluation reports for nanosafety Databases for safety assessment
11 3RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23rd March 2010 Understanding the biological response Size and Shape Size distribution Shape State of Dispersion Agglomeration/Aggregation Physical and Chemical Properties Chemical composition Crystalline phase and crystallite le c i t size r a op s Solubility Nan c i t s i r Impurities haracte C Surface Area and Porosity Surface Properties Surface composition Catalytic properties Surface charge Reactivity Adsorption/desorption of molecules Lipophilicity/hydrophilicity 11 EFFECT Translocation from GI-tract to target organs Protein binding Cellular uptake Accumulation and retention Toxicity Cell/tissue response
12 12 3RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23rd March 2010 Nanotoxicology Systems Response In vivo Engineered Nanomaterials Biol. Response, pathogenicity In vitro Kinetics/ADE In vivo Uptake Accumulation Tissue and Cell Responses
13 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Nanomaterials tested at JRC
14 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Characterisation Techniques Size Morphology Concentration, Purity Proteins Interaction Uptake, Protein Interaction Particle-by-particle size distribution analysis Dynamic Light Scattering Scanning Electron Microscope Inductively Coupled Plasma Mass Spectrometry Fast Protein Liquid Chromatography Surface Plasmon Resonance 24 nm
15 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March In vitro toxicological profile NR CFE MTT Micronucleus test Cytocotoxicity Interaction with cells Inflammation Oxidative Stress NPs STEM analysis Cell transformation assay Genotoxicity Cancerogeneous Potential
16 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Result: Dose-Effect Relationship Unexposed cells 10µM Cytotoxicity Colony Forming Efficiency test in Balb/3T3 Cobalt nanoparticles (80 nm) 30µM 50µM Inhibitory Concentration 50% (IC50) 70µM 100µM Cell viability (%) Concentration (µm)
17 Repository: NM for testing 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March
18 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March IT Platform - NAPIRAhub NAPIRAhub is a comprehensive IT platform dedicated to the management of information on nanomaterials, relevant for safety/risk assessment. FEATURES Built on proven technology (IUCLID 5). Stores information/data structured in accordance with OECD and ISO guidelines and harmonised templates. Facilitates exchange and merging of datasets. Tracks changes to ensure traceability and reliability. Extensive search capabilities. Supplied free-of-charge by JRC, with support (
19 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Nanotechnology at IHCP Nanobiotechnology NM properties NM test method adaptation Innovative nano-applications Nanosafety and Regulatory Methods Nanosafety of substances and products Test methods- regulatory issues Radiotracers NM radiolabelling NM radioactivation Assay Technologies High Throughput assays and automation Repository: Nanomaterials for testing In vitro Methods Optimisation Test Method Optimization Test Method Validation
20 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March NANOMATERIALS SAFETY RESEARCH at JRC Methodology Test methods for nanomaterials (NM) Advanced characterisation methods Assay automation for High Throughput (HTS) Implementation tools Repository: Nanomaterial for testing NAPIRAhub information platform Validation for test methods Data for safety assessment Research projects FP6, FP7 ACT-ECO CELL-NANO-TOX INTELTEX CAREMAN BIOMONAR NANOIMPACTNET NEURONANO ENRHES NANORETOX NANOTHER PepChipOmics NHECD NANEX ENPRA
21 3 RD CIAA NANOTECHNOLOGY DIAOLOGUE MEETING, Brussels, 23 rd March Joint Research Centre (JRC) Robust science for policy making Thank you for your attention Web: Contact:
Safe Nanotechnology EU Industrial Research
Safe Nanotechnology EU Industrial Research Georgios Katalagarianakis EC, Research DG Industrial Technologies Directorate G4 Nanoscience - Nanotechnology 1 summary Policy; Towards a second Action Plan 2010-2015
More informationWhat is nanotoxicology?
What is nanotoxicology? How to estimate the potential hazard related to nanoparticles? Dissemination report October 2008 DR-225 200810-5 Project ID NMP2-CT-2005-515843 An European Integrated Project Supported
More informationJRC and GMES GIO-EMS
Joint Research Centre JRC and GMES GIO-EMS Guido Lemoine, Jan Kucera, Marco Broglia JRC, Ispra 1st GMES NATIONAL USER FORUM DAY Prague, 29-30 May 2012 Serving society Stimulating innovation Supporting
More informationNano-Titanium Dioxide in Sunscreens. Gerald Renner, Colipa
Nano-Titanium Dioxide in Sunscreens Gerald Renner, Colipa Cosmetic Use of Nanomaterials In 2008, a survey of nanomaterials sold in EU cosmetic products amongst member companies of Colipa and national trade
More informationParticipatory Honeypots: A Paradigm Shift in the Fight Against Mobile Botnets
Participatory Honeypots: A Paradigm Shift in the Fight Against Mobile Botnets Pasquale Stirparo (@pstirparo) Laurent Beslay www.jrc.ec.europa.eu Serving society Stimulating innovation Supporting legislation
More informationREGULATORY RISK ASSESSMENT OF NANOMATERIALS IN THE EU
REGULATORY RISK ASSESSMENT OF NANOMATERIALS IN THE EU Karin Aschberger 1, Nanna Hartmann 1,2, Stefania Gottardo 1, Zuzana Klöslova 3, Julia Fabrega Climent 3, Valeria Amenta 1, Frans M. Christensen 1,4
More informationOverview on EFSA data requirements for the safety evaluation of food enzymes applications
Overview on EFSA data requirements for the safety evaluation of food enzymes applications Fidel Toldrá and Klaus-Dieter Jany EFSA CEF Panel Info session on Food Enzymes applications Parma, 27 May 2014
More informationRisk Assessment of nanomaterials from an industry perspective. Jenny Holmqvist
Risk Assessment of nanomaterials from an industry perspective Jenny Holmqvist European Chemical Industry Council - Cefic We are the forum and the voice of the chemical industry in Europe With a Brussels
More informationCURRENT CHALLENGES IN BIO- METROLOGY: THE JRC SUPPORT TO FOOD SAFETY POLICIES. Queretaro, 22-24 October, 2008
1 CURRENT CHALLENGES IN BIO- METROLOGY: THE JRC SUPPORT TO FOOD SAFETY POLICIES CENAM Symposium of Metrology Queretaro, 22-24 October, 2008 Alejandro Herrero Institute for Reference Materials and Measurements
More informationIndustrie-Perspective: Wie gesund sind Nanomaterialien?
- Chemische Abendgespräch - Thema: Sind Nanomaterialien überhaupt gesund? Industrie-Perspective: Wie gesund sind Nanomaterialien? Sind Nanomaterialien überhaupt gesund? 1 What is healthy? What is it used
More informationJoint Research Centre
Joint Research Centre Supporting research, technological development and innovation European Commission DG Joint Research Centre Foresight and Horizon Scanning Foresight and Behavioural Insight Unit Fabiana
More informationSafe Nano Design Molecule Manufacturing Market
August 14 16, 212 College of Nanoscale Science & Engineering (CNSE) of the University at Albany National Institute for Occupational Safety and Health (NIOSH) Prevention through Design Program Safe Nano
More informationExternal stakeholder events and projects on nanomaterials and nanotechnologies
BUSINESS AND INDUSTRY ADVISORY COMMITTEE (BIAC) PART I: ACC The American Chemistry Council Nanotechnology Panel (Panel) presented at numerous national and international presentations and workshops on nanotechnology
More informationApplications of nanotechnology: Cosmetics
Applications of nanotechnology: Cosmetics Course on Health Effects of Engineered Nanomaterials Finnish Institute of Occupational Health, 23 April 2013 Sari Karjomaa Finnish Cosmetic, Toiletry and Detergent
More informationSome activities in JRC of relevance for Swedish scientists
Some activities in JRC of relevance for Swedish scientists Peter Pärt Advisor to the Director, Institute Environment and Sustainability www.jrc.ec.europa.eu Serving society Stimulating innovation Supporting
More informationBiological importance of metabolites. Safety and efficacy aspects
Biological importance of metabolites Safety and efficacy aspects Bernard Walther Technologie Servier Biological importance of metabolites Safety testing of drug metabolites Bioanalytical strategy Structural
More informationTOWARDS A STRATEGIC NANOTECHNOLOGY ACTION PLAN (SNAP) 2010-2015
TOWARDS A STRATEGIC NANOTECHNOLOGY ACTION PLAN (SNAP) 2010-2015 1. Respondent profile For individuals: - Name, age, gender, country, e-mail. - From which perspective are you interested in nanotechnologies:
More informationECHA s Regulatory Science Strategy
ECHA s Regulatory Science Strategy 2 ECHA s Regulatory Science Strategy Reference: ECHA-15-A-03-EN Publ.date: February 2015 Language: EN European Chemicals Agency, 2015 If you have questions or comments
More informationMODERN. Collaborative Project. Topic NMP.2012.1.3-2: Modeling toxicity behavior of engineered nanoparticles
Project No. 309314 MODERN MODELING THE ENVIRONMENTAL AND HUMAN HEALTH EFFECTS OF NANOMATERIALS Collaborative Project Topic NMP.2012.1.3-2: Modeling toxicity behavior of engineered nanoparticles D4.2 Disseminating
More informationNANOfutures association. Overview of NANOfutures Approach and Activities http://www.nanofutures.eu
NANOfutures association Overview of NANOfutures Approach and Activities http://www.nanofutures.eu NANOfutures Initiative NANOfutures is an European Integration and Innovation Platform of which main objective
More informationIRGC Annual Event 2011 Roundtable 2
IRGC Annual Event 2011 Roundtable 2 EU Regulatory Context for Innovative Technologies Dr. Anna Gergely, Director EHS Regulatory agergely@steptoe.com 3 November 2011 Lausanne, Switzerland 1 CONTENT 1. Why
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
More informationCorrosion and SCC material testing in SCW in JRC IET Petten
# Joint Research Centre (JRC) Safety of Future Nuclear Reactors Unit AMALIA laboratory Corrosion and SCC material testing in SCW in JRC IET Petten R. Novotny, P. Moilanen*, P. Janik, S. Penttilä*, P. Hähner,
More informationRisk assessment and regulation of tattoo inks in the EU
Risk assessment and regulation of tattoo inks in the EU Paul Janssen Current situation: Tattoo application in a regulatory vacuum : Is not a medical treatment Is not a cosmetic treatment No EU-regulation
More informationEU Customs Detection Technology Expert group Towards rational use of detection technology
EU Customs Detection Technology Expert group Towards rational use of detection technology Wil van Heeswijk Directorate General for Taxation and Customs Union Risk management and Security unit Brussels,
More informationaamg Airborne Particles: Origins, composition and effects Airborne Particles: Origins, composition and effects Programme and call for posters
Airborne Particles: Origins, composition and effects Email: conference@aamg-rsc.org Web site: www.aamg-rsc.org Advancing the Chemical Sciences aamg Monitoring Ambient Air 2008 Airborne Particles: Origins,
More informationROADMAP. A. Context and problem definition
ROADMAP TITLE OF THE INITIATIVE Defining criteria for identifying Endocrine Disruptors in the context of the implementation of the Plant Protection Product Regulation and Biocidal Products Regulation LEAD
More informationA FDA Perspective on Nanomedicine Current Initiatives in the US
A FDA Perspective on Nanomedicine Current Initiatives in the US Carlos Peña, PhD Office of the Commissioner FDA September 3, 2010 Outline Context Nanotechnology Task Force report summary Identification
More informationGUIDANCE ON THE SAFETY ASSESSMENT OF NANOMATERIALS IN COSMETICS
Scientific Committee on Consumer Safety SCCS GUIDANCE ON THE SAFETY ASSESSMENT OF NANOMATERIALS IN COSMETICS The SCCS adopted this opinion at its 15 th plenary meeting of 26 27 June 2012 About the Scientific
More informationOverview of pipelines in Europe advantages and disadvantages
Overview of pipelines in Europe advantages and disadvantages Dr. Georgios A. Papadakis Industrial Risk Management Technical University of Crete,, Greece tel: : +30-28210 28210-37316 e-mail: gpap@dpem.tuc.gr
More informationQUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES
QUESTIONS AND ANSWERS ABOUT THE EDQM ACTIVITIES Why are Pharmacopoeias so important in a globalised world? Pharmacopoeias have historically provided collections of medical recipes intended to ensure accurate
More informationRisk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC)
Scientific Committee on Health and Environmental Risks SCHER Risk Assessment Report on (3-CHLORO-2-HYDROXYPROPYL)TRIMETHYLAMMONIUM CHLORIDE (CHPTAC) Human Health Part CAS No.: 3327-22-8 EINECS No.: 222-048-3
More informationGlobal Biodiversity Sub-Committee (GBSC) Meeting papers
Global Biodiversity Sub-Committee (GBSC) Meeting papers Nanotechnology and biodiversity: an initial consideration of whether research on the implications of nanotechnology is adequate for meeting aspirations
More informationThe Risk Prevention Management System of the European Commission's staff
The Risk Prevention Management System of the European Commission's staff Calvo Alonso-Cortés, Antonio Directorate-General "Human Resources and Security" 200, Rue de la Loi, B-1049- Brussels, Belgium Phone:
More informationProposal for a RECOMMENDATION OF THE EUROPEAN COMMISSION
EUROPEAN COMMISSION Brussels, XXX [ ] (2013) XXX draft Proposal for a RECOMMENDATION OF THE EUROPEAN COMMISSION Providing minimum principles for the exploration and production of hydrocarbons (especially
More informationExploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program
More informationRisk assessment and life cycle assessment for engineered nanomaterials: highlights from NanoValid
www.nanovalid.eu MARINA NanoValid conference 29 September 2015 Risk assessment and life cycle assessment for engineered nanomaterials: highlights from NanoValid Dana Kühnel and all WP4 Partners This project
More informationThe Biocidal Products Regulation. Latest developments
The Biocidal Products Regulation Latest developments Eleventh Antimicrobial Workshop March 10-11, 2015 Hyatt Regency Crystal City Arlington, VA Pierre Choraine European Commission DG SANTE, Unit E.3 ECHA
More informationTask Force Nanoscience. Luigi Manzo. Titanium Dioxide Project Development
Task Force Nanoscience Titanium Dioxide Project Development Luigi Manzo S. Maugeri Medical Centre Department of Internal Medicine University of Pavia 3rd National N.I.C. Conference, Milano, 2-3 December
More informationRADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
More informationProduction of ferrite nanopowders in radiofrequency thermal plasma
Production of ferrite nanopowders in radiofrequency thermal plasma PhD Theses Loránd Gál Budapest, 2008 HAS Chemical Research Center Institute of Materials and Environmental Chemistry Department of Plasma
More informationFACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
More informationICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS
More informationThe EC Joint Research Centre on Aviation Security
The EC Joint Research Centre on Aviation Security Göran Lövestam Joint Research Centre www.jrc.ec.europa.eu Serving society Stimulating innovation Supporting legislation The Joint Research Centre (JRC)
More informationEuropean Conference on Safe Use of Plant Protection Products
European Conference on Safe Use of Plant Protection Products Conference Report, 18 June 2014 In June 2014, the Federal Institute for Risk Assessment in Germany (BfR) and the European Commission hosted
More informationReport on Early Harvest of Research Results on Nanosafety
Report on Early Harvest of Research Results on Nanosafety Summary of the 1st Joint CASG Nano and ENPRA Workshop held on 14-15 april 2010 at the Institute for Health and Consumer Protection, IHCP (Ispra,
More informationAccelerating Lead Generation: Emerging Technologies and Strategies
Brochure More information from http://www.researchandmarkets.com/reports/1057249/ Accelerating Lead Generation: Emerging Technologies and Strategies Description: The number of approvals for new drugs and
More informationCall 2014: High throughput screening of therapeutic molecules and rare diseases
Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for
More informationChapter 8. Summary and Perspectives
Chapter 8 Summary and Perspectives 131 Chapter 8 Summary Overexpression of the multidrug resistance protein MRP1 confer multidrug resistance (MDR) to cancer cells. The contents of this thesis describe
More informationOpinion of the Panel on food contact materials, enzymes, flavourings and processing aids (CEF)
The EFSA Journal (2009) 1208 Opinion of the Panel on food contact materials, enzymes, flavourings and processing aids (CEF) Guidelines on submission of a dossier for safety evaluation by the EFSA of active
More informationAdvanced BioDesign Outlines Solutions. Antibody Overview. by Advanced BioDesign. Project Start. Immunogenicity. Selecting Your Antigen
Advanced BioDesign Outlines Solutions by Advanced BioDesign Antibody Overview Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, you may develop
More informationGHS implementation in EU - The CLP Regulation -
GHS implementation in EU - The CLP Regulation - Lennart Dock lennart.dock@kemi.se Swedish Chemicals Agency GHS Stocktaking Workshop for Central and Eastern Europe Chisinau, Republic of Moldova 7-9 July
More informationPBT profiling of pre-registered substances by QSAR methods & determination of QSARs Applicability domain
1 PBT profiling of pre-registered substances by QSAR methods & determination of QSARs Applicability domain Klaus Daginnus Institute for Health & Consumer Protection Joint Research Centre, European Commission
More informationMaking chemicals safer: Towards 2020
4 th National Conference on REACH 16 December 2013 Rome Cristina de Avila European Commission DG Environment Making chemicals safer: Towards 2020 Chemicals in the EU a large sector 3rd manufacturing sector
More informationIMPURITIES IN NEW DRUG PRODUCTS
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current
More informationBBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS 1. The Technology Strategy sets out six areas where technological developments are required to push the frontiers of knowledge
More informationEdward Odenkirchen, Ph.D. Office of Pesticide Programs US Environmental Protection Agency
Edward Odenkirchen, Ph.D. Office of Pesticide Programs US Environmental Protection Agency 1 Mission Statement Best possible regulatory decisions to protect public health and environment. Rely on all best
More informationApplication Note No. 2 / July 2012. Quantitative Assessment of Cell Quality, Viability and Proliferation. System
Application Note No. 2 / July 2012 Quantitative Assessment of Cell Quality, Viability and Proliferation System Quantitative Assessment of Cell Quality, Viability and Proliferation Introduction In vitro
More informationIUCLID 5 COMPOSITION AND ANALYSIS GUIDANCE DOCUMENT: IRON ORES, AGGLOMERATES [EINECS NUMBER 265 996 3, CAS NUMBER 65996 65 8] IRON ORE PELLETS
IUCLID 5 COMPOSITION AND ANALYSIS GUIDANCE DOCUMENT: IRON ORES, AGGLOMERATES [EINECS NUMBER 265 996 3, CAS NUMBER 65996 65 8] IRON ORE PELLETS INTRODUCTION Each REACH registrant is required to file its
More informationElectron microscopy as an analytical tool for detection and characterization of inorganic nanoparticles in food. EU Framework Programme 7-Nanolyse
Electron microscopy as an analytical tool for detection and characterization of inorganic nanoparticles in food EU Framework Programme 7-Nanolyse Nanostructures in food 1. Natural e.g. milk proteins 2.
More informationDevelopment of an inventory for consumer products containing nanomaterials Final Report 070307/2010/580587/SER/D3
Development of an inventory for consumer products containing nanomaterials Final Report 070307/2010/580587/SER/D3 Colophon Dr. S.W.P. Wijnhoven Dr. Ir. A.G. Oomen Dr. A.J.A.M. Sips Drs. F.C. Bourgeois
More informationGUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS
GUIDELINES FOR THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS -ii- GUIDELINES ON THE REGISTRATION OF BIOLOGICAL PEST CONTROL AGENTS FOOD AND
More informationWHAT S NEW IN ALTERNATIVES?
WHAT S NEW IN ALTERNATIVES? Joanne Zurlo, PhD Center for Alternatives to Animal Testing (CAAT) Johns Hopkins Bloomberg School of Public Health Baltimore, MD What are alternatives? Alternative are sometimes
More informationM.Sc. in Nano Technology with specialisation in Nano Biotechnology
M.Sc. in Nano Technology with specialisation in Nano Biotechnology Nanotechnology is all about designing, fabricating and controlling materials, components and machinery with dimensions on the nanoscale,
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 15 to the EU Guide to Good Manufacturing Practice
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working Party on Control
More informationAOP Knowledge Base/ Wiki Tool Set
AOP Knowledge Base/ Wiki Tool Set Stephen W. Edwards Adverse Outcome Pathways: From Research to Regulation This talk does not necessarily reflect the views of the Environmental Protection Agency. Photo
More informationGUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.
GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS October 2004 APVMA PO Box E240 KINGSTON 2604 AUSTRALIA http://www.apvma.gov.au
More informationRead-across and alternative testing strategies for REACH 2018
Read-across and alternative testing strategies for REACH 2018 Jeannette Paulussen, Ph.D. June 24, 2015 Content REACH & Alternative testing strategies In vitro testing and study waivers QSARs and Annex
More informationSTATEMENT BY THE UK GOVERNMENT ABOUT NANOTECHNOLOGIES
STATEMENT BY THE UK GOVERNMENT ABOUT NANOTECHNOLOGIES INDEX 1. UK Government s vision for nanotechnologies 2. What are nanotechnologies? 3. How the UK Government is looking to promote the opportunities
More informationComparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
More informationHorizon 2020 Proposal: CAT-APP
ENVIRONMENTAL SCIENCE FOR THE EUROPEAN REFINING INDUSTRY Horizon 2020 Proposal: CAT-APP New methods to Underpin Category Approaches and Read Across in Regulatory Programmes Hans Ketelslegers Summary 2
More informationHow To Monitor Toxicity In Water
1 WORKSHOP AND OPEN TECHNICAL MEETING WITH A VERIFICATION EXERCISE: Towards a European ETV Environmental Technology Verification System. Barcelona. 20-22 February 2008 AUTOMATED MICROBIAL BIOSENSORS FOR
More informationEx-post Evaluation Joint Research Centre Direct Actions in the 6 th Framework Programmes 2002-2006. Final Report
Ex-post Evaluation Joint Research Centre Direct Actions in the 6 th Framework Programmes 2002-2006 Final Report September 2008 Ex-post Evaluation Joint Research Centre Direct Actions in the 6 th Framework
More informationEFSA explains the carcinogenicity assessment of glyphosate
PESTICIDES UNIT EFSA explains the carcinogenicity assessment of glyphosate Background 12 November 2015 During the EFSA peer-review process for the renewal of the approval of the pesticide active substance
More informationPROVIDING TECHNICAL SOLUTIONS FOR BIOLOGICAL PROCESSES AND MEDICAL DEVICES
PROVIDING TECHNICAL SOLUTIONS FOR BIOLOGICAL PROCESSES AND MEDICAL DEVICES ABOUT LIFE SCIENCES ENGINEERING The joint Life Sciences Engineering business unit of Fraunhofer IPT and CMI has offices in Boston,
More informationChemical safety and big data: the industry s demands
Chemical safety and big data: the industry s demands Richard CURRIE Senior Technical Expert; Group Leader & Global Predictive and Computational Toxicology Lead Valid results Useful results Credit Money/Grants
More informationTOOLS sirna and mirna. User guide
TOOLS sirna and mirna User guide Introduction RNA interference (RNAi) is a powerful tool for suppression gene expression by causing the destruction of specific mrna molecules. Small Interfering RNAs (sirnas)
More informationEfficiency of fibrous filters and personal protective equipments against nanoaerosols. Dissemination report January 2008 DR-325/326-200801-1
Are conventional protective devices such as fibrous filter media, cartridge for respirators, protective clothing and gloves also efficient for nanoaerosols? Efficiency of fibrous filters and personal protective
More informationCHEMICAL SENSORS 1. DEFINITION
CHEMICAL SENSORS 1. DEFINITION A chemical sensor is a device that transforms chemical information (composition, presence of a particular element or ion, concentration, chemical activity, partial pressure
More informationPractical Guide 6. How to report read-across and categories
Practical Guide 6 How to report read-across and categories 2 Practical Guide 6 2.0 Version Changes Date Version 1.0 First version. March 2010 Version 2.0 Revision of the Practical guide addressing structure
More informationGuidance for Industry
Guidance for Industry Q2B Validation of Analytical Procedures: Methodology November 1996 ICH Guidance for Industry Q2B Validation of Analytical Procedures: Methodology Additional copies are available from:
More informationThermo Scientific icap 7000 Series ICP-OES. Low cost ICP-OES analysis high quality data
Low cost ICP-OES analysis high quality data The NEW Thermo Scientific icap 7000 Series ICP-OES provides low cost multi-element analysis for measuring trace elements in a diverse sample range. The instrument
More informationREACH and Safety Data Sheets
This leaflet explains the requirements for safety data sheets and how they will change in the future. What is REACH? REACH (Registration, Evaluation, Authorisation and restriction of Chemicals) is the
More informationRenewable Energy Certificate systems in Europe (the path to international trade)
Renewable Energy Certificate systems in Europe (the path to international trade) Marcel Galjee Board member RECS International Athens, March 31 st 2004 Outline of the presentation About RECS RECS International
More informationThermo Scientific Prelude SPLC System FPO. Making LC/MS accessible. to clinical research and toxicology labs
Thermo Scientific Prelude SPLC System FPO Making LC/MS accessible to clinical research and toxicology labs Specifically designed to make the power of LC/MS accessible Analysis of target compounds in complex
More informationFrequently asked questions on the procedure for the re-assessment of glyphosate within the framework of the EU active substance review
Frequently asked questions on the procedure for the re-assessment of glyphosate within the framework of the EU active substance review BfR FAQ, 12 November 2015 Active substances used in pesticides are
More informationBiopharmaceutical Process Evaluated for Viral Clearance
Authored by S. Steve Zhou, Ph.D. Microbac Laboratories, Inc., Microbiotest Division The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate
More informationProtocol for Disinfection of Cell Culture and Tissue Culture in Media:
Protocol for Disinfection of Cell Culture and Tissue Culture in Media: Location: Hickory Hall 001 Director: Dr. Guido Verbeck DECONTAMINATION OF CELL CULTURE WASTE Cell culture has become a common laboratory
More information- A9/1 - Format for the listing of end points to be included in the Tier III overall summary and assessments
- A9/1 - - A9/1 - APPENDIX 9 FORMAT FOR THE LISTING OF END POINTS TO BE INCLUDED IN THE REASONED STATEMENT OF THE OVERALL CONCLUSIONS DRAWN BY THE REGULATORY AUTHORITY (LEVEL 2)8 General remark: Testing
More informationINTEGRATING STANDARDS IN YOUR HORIZON 2020 PROJECT. Linking R&D and Standardization: a pocket guide for project proposers
INTEGRATING STANDARDS IN YOUR HORIZON 2020 PROJECT Linking R&D and Standardization: a pocket guide for project proposers Table of contents Standards support research & innovation... 3 Do you need standards?.....................................................................
More informationNanotechnology and the Environment. Nine Zeros Nanotechnology Breakfast Roundtable October 4, 2004
Nanotechnology and the Environment Nine Zeros Nanotechnology Breakfast Roundtable October 4, 2004 Nanotechnology and the Environment Robert C. Kirsch, Esq. robert.kirsch@wilmerhale.com (617) 526-6779 Mark
More informationKey Results of 2008 Leem Nanomedecine Study
Key Results of 2008 Leem Nanomedecine Study Nanobio Dialogue Session Annick Schwebig,, M.D., General Manager, Actelion Pharmaceuticals France Vice-President of Leem Biotech Committee EuroBio,, Paris, October
More informationDr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
More informationDMPK: Experimentation & Data
DMPK: Experimentation & Data Interpretation Mingshe Zhu, Mike S. Lee, Naidong Weng, and Mark Hayward Prerequisite: Entry-level scientists with hands on experience in LC/MS as well as advanced students
More informationAttivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri
Roma IZSLT 30 Novembre 2010 1 Attivita del Laboratorio Europeo di Riferimento sugli OGM (EURL-GMFF) in supporto al sistema di controllo ufficiale degli Stati Membri Marco Mazzara Joint Research Centre,
More informationDEVELOPMENT OF NOVEL NANOTECHNOLOGY BASED DIAGNOSTIC SYSTEMS FOR RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS FP7-NMP-2008-LARGE-2
1 DEVELOPMENT OF NOVEL NANOTECHNOLOGY BASED DIAGNOSTIC SYSTEMS FOR RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS FP7-NMP-2008-LARGE-2 Margarethe Hofmann-Amtenbrink Scientific Coordination Seminar Standards and
More informationNon-clinical development of biologics
Aurigon Life Science GmbH Non-clinical development of biologics Requirements, challenges and case studies Committed to Life. Sigrid Messemer vet. med. M4 Seminar March 10 th 2014 Aurigon - your full service
More informationGood Manufacturing Practices for the Production of Packaging Inks formulated for use on the non food contact surfaces of food packaging and articles
Good Manufacturing Practices for the Production of Packaging Inks formulated for use on the non food contact surfaces of food packaging and articles intended to come into contact with food October 2005
More informationBIOTECHNOLOGY OPERATIONS
BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press
More information